Cited by 65Nitric Oxide and Endothelin EffectsCardiac Ischemia and ReperfusionCalcium signaling and nucleotide metabolism

Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion

Open access
Boslett, James, Hemann, Craig, Christofi, Fedias L., Zweier, Jay L.·2018·American Journal of Physiology-Cell Physiology

Abstract

The NAD(P) + -hydrolyzing enzyme CD38 is activated in the heart during the process of ischemia and reperfusion, triggering NAD(P)(H) depletion. However, the presence and role of CD38 in the major cell types of the heart are unknown. Therefore, we characterize the presence and function of CD38 in cardiac myocytes, endothelial cells, and fibroblasts. To comprehensively evaluate CD38 in these cells, we measured gene transcription via mRNA, as well as protein expression and enzymatic activity. Endothelial cells strongly expressed CD38, while only low expression was present in cardiac myocytes with intermediate levels in fibroblasts. In view of this high level expression in endothelial cells and the proposed role of CD38 in the pathogenesis of endothelial dysfunction, endothelial cells were subjected to hypoxia-reoxygenation to characterize the effect of this stress on CD38 expression and activity. An activity-based CD38 imaging method and CD38 activity assays were used to characterize CD38 activity in normoxic and hypoxic-reoxygenated endothelial cells, with marked CD38 activation seen following hypoxia-reoxygenation. To test the impact of hypoxia-reoxygenation-induced CD38 activation on endothelial cells, NAD(P)(H) levels and endothelial nitric oxide synthase (eNOS)-derived NO production were measured. Marked NADP(H) depletion with loss of NO and increase in superoxide production occurred following hypoxia-reoxygenation that was prevented by CD38 inhibition or knockdown. Thus, endothelial cells have high expression of CD38 which is activated by hypoxia-reoxygenation triggering CD38-mediated NADP(H) depletion with loss of eNOS-mediated NO generation and increased eNOS uncoupling. This demonstrates the importance of CD38 in the endothelium and explains the basis by which CD38 triggers post-ischemic endothelial dysfunction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpcell.00139.2017

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Boslett, J., Hemann, C., Christofi, F. L., & Zweier, J. L.
Affiliations
  • The Ohio State University (US)
  • The Ohio State University Wexner Medical Center (US)
Corresponding author
Zweier, Jay L.
Venue
American Journal of Physiology-Cell Physiology
Published
2018-03-01
Volume
314
Issue
3
Pages
C297-C309
ISSN
  • 0363-6143 (ISSN-L)
  • 1522-1563
OpenAlex
W2769944289
Cited by
65
References
57
Citations by year
2026: 9 · 2025: 3 · 2024: 9 · 2023: 10 · 2022: 12 · 2021: 8 · 2020: 5 · 2019: 4 · 2018: 5
FWCI
2.83
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Cell Physiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
HHS | National Institutes of Health (HL131941, HL135648)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
Keywords
CD38, endothelial cells, hypoxia/reoxygenation, endothelial dysfunction, cardiomyocytes, cardiac fibroblasts, endothelial nitric oxide synthase, eNOS uncoupling, nitric oxide, superoxide, myocardial ischemia-reperfusion injury
MeSH terms
Animals, Coronary Vessels, Enzyme Activation, Fibroblasts, Membrane Glycoproteins, Mice, Inbred C57BL, NADP, Nitric Oxide, Superoxides, Time Factors, Signal Transduction, Myocardial Reperfusion, Myocardial Reperfusion Injury, Cell Hypoxia, Rats, Sprague-Dawley, Mice, Knockout, Myocytes, Cardiac, ADP-ribosyl Cyclase, Endothelial Cells, ADP-ribosyl Cyclase 1, Nitric Oxide Synthase Type III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review